Addex Therapeutics (ADXN)

Addex Therapeutics (ADXN) Financial Statements


Addex Therapeutics Financial Overview

Addex Therapeutics's market cap is currently ―. The company's EPS TTM is $-17.949; its P/E ratio is -0.46; Addex Therapeutics is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--CHF 409.42KCHF 183.35KCHF 237.24K
Gross Profit-----
EBIT--CHF -4.10MCHF -7.21MCHF -5.76M
EBITDA--CHF -4.02MCHF -7.13MCHF -5.68M
Net Income Common Stockholders--CHF -4.11MCHF -7.22MCHF -5.82M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsCHF 3.87MCHF 6.96MCHF 10.43MCHF 8.82MCHF 14.90M
Total AssetsCHF 4.64MCHF 8.28MCHF 12.24MCHF 11.38MCHF 17.68M
Total DebtCHF 70.38KCHF 373.13KCHF 447.11KCHF 336.95KCHF 412.87K
Net DebtCHF -3.80MCHF -6.58MCHF -9.98MCHF -8.48MCHF -14.48M
Total LiabilitiesCHF 3.50MCHF 30.29MCHF 4.29MCHF 4.52MCHF 4.73M
Stockholders EquityCHF 1.15MCHF -22.03MCHF 7.95MCHF 6.86MCHF 12.96M
Cash Flow-
Free Cash Flow--CHF -2.69MCHF -5.83MCHF -4.84M
Operating Cash Flow--CHF -2.69MCHF -5.83MCHF -4.84M
Investing Cash Flow--CHF 2.98KCHF 0.00CHF 0.00
Financing Cash Flow--CHF 4.19MCHF -170.25KCHF -744.35K
Currency in CHF

Addex Therapeutics Earnings and Revenue History

Addex Therapeutics Debt to Assets

Addex Therapeutics Cash Flow

Addex Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis